Newsletter | February 26, 2025

02.26.25 -- In Clinical Research, Every Day Is Groundhog Day

SPONSOR

What’s the real impact of the "one-and-done PI" in clinical trials? Some say it’s a major issue, while others question if it’s a concern at all. Clinical Leader Live’s expert panel—backed by research—dives into the data, debate, and potential solutions. Join this free digital event!

DECENTRALIZED TRIALS

In Clinical Research, Every Day Is Groundhog Day

Guest Column | By Paul Ivsin

Rather than proffer some New Year's predictions, Paul Ivsin looks at clinical research through the lens of Groundhog Day and the tradition of reinventing the same thing over and over again.

DECENTRALIZED TRIALS - INDUSTRY INSIGHTS

Deconstructing Central Rating In Clinical Trials

Article | By Juliet Brown, Ph.D., Joan Busner, Ph.D., Daniela Chereches, and Margot Oakley, Signant Health

Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success.

5 Essential Capabilities For Decentralized Clinical Trials

White Paper | Quest Diagnostics

Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.

TRIAL MANAGEMENT

Roche Diagnostics Guides New Alzheimer's Test Through Trials

Guest Column | A conversation with Maria-Magdelena Patru, MD, Ph.D., Roche Diagnostics

Roche Diagnostics’ Maria-Magdelena Patru, MD, PhD discusses their plasma test and how they’re approaching its clinical trials. 

'Diabesitology': Novel Trial Designs In The GLP-1 Axis Medications Era

Article | By Jamie P. Dwyer, MD, Biorasi

Find out how today’s FDA-approved obesity medications are primed to become tomorrow’s novel treatments across multidimensional states of disease — from diabetes to heart failure.

How To Establish Effective, Scalable Drug Safety Ops Across Vendors

Article | By Rosa Lee Smith and Raul P. Lima, inSeption Group and Elizabeth Delmaestro, Independent Consultant 

Numerous factors impact a drug safety program, but proper management of three key elements drives success while creating a scalable drug safety model.

Breaking Barriers In Drug Development: Putting Patients First

Article | By Moisha Platto, Scout

Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.

Pharmaceutical Clinical Trial Distribution Services

Product | Ropack Pharma Solutions

Contracting an in-country pharmaceutical clinical depot brings efficiencies to your clinical trial distribution. Learn about Ropack Pharmaceutical Clinical Distribution Depot and regulatory processes.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: